Jeni L. Burgess I

Pharmacist



  
  750 E Adams St, Syracuse
New York, 13210-2306

 315-464-4210   
Jeni L. Burgess I is a pharmacist in Syracuse, New York. Patients can reach her at 750 E Adams St, Syracuse or contact her on 315-464-4210. Active license number of Jeni L. Burgess I is 056312 for Pharmacist in New York.
Jeni L. Burgess I is


Complete Profile:
Jeni L. Burgess I speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Jeni L. Burgess I
Specialization: Pharmacist
Credentials:PHARMD
Gender:Female
Location:750 E Adams St, Syracuse,
New York, 13210-2306
Phone:315-464-4210
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jeni L. Burgess I are as mentioned below.
NPI Number: 1972448207
NPI Enumeration Date: 22 Apr, 2026
NPI Last Update On: 22 Apr, 2026

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jeni L. Burgess I are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist 056312New YorkPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 750 East Adams St., Department Of Pharmacy Rm 5408,
Syracuse, New York
Zip: 13210
Phone Number: 315-464-4210
Patients can reach Jeni L. Burgess I at 750 E Adams St, Syracuse, New York or can call on phone at 315-464-4210.

Comments/ Reviews:
Read all the reviews posted for Jeni L. Burgess I below. You may also share your own experience with Jeni L. Burgess I. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 July, 2026.